BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 10, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» Orbis to use Vivtex platform for gut permeability screening
To read the full story,
subscribe
or
sign in
.
Drug design, drug delivery & technologies
Orbis to use Vivtex platform for gut permeability screening
Sep. 18, 2024
Orbis Medicines SA has announced a research collaboration and option to an exclusive license with Vivtex Corp.
BioWorld Science
Deals and M&A
Drug design, drug delivery and technologies
Collaboration
Gastrointestinal
Small molecule
